154 related articles for article (PubMed ID: 10354292)
1. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
Hu P; Lu L; Hu B; Du PF
Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
[TBL] [Abstract][Full Text] [Related]
7. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.
Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
Eur J Clin Invest; 2000 Oct; 30(10):866-70. PubMed ID: 11029600
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
[TBL] [Abstract][Full Text] [Related]
10. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
Faucher C; Doucet C; Baumelou A; Chapman J; Jacobs C; Thillet J
Am J Kidney Dis; 1993 Dec; 22(6):808-13. PubMed ID: 8250027
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
13. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
Nakahara C; Kobayashi K; Hamaguchi H; Kanemoto K; Kashiwagi R; Matsui A
Pediatr Nephrol; 1999 Oct; 13(8):657-61. PubMed ID: 10502122
[TBL] [Abstract][Full Text] [Related]
15. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
[TBL] [Abstract][Full Text] [Related]
16. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
[TBL] [Abstract][Full Text] [Related]
17. Lipopheresis in the nephrotic syndrome.
Brunton C; Varghese Z; Moorhead JF
Kidney Int Suppl; 1999 Jul; 71():S6-9. PubMed ID: 10412726
[TBL] [Abstract][Full Text] [Related]
18. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
Kimak E; Solski J
Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
[TBL] [Abstract][Full Text] [Related]
19. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
Brown CD; Azrolan N; Thomas L; Roberts KG; Bostom A; Zhao ZH; Friedman EA
Am J Kidney Dis; 1995 Jul; 26(1):170-7. PubMed ID: 7611249
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
